News

In tough environment, Lantheus has cash and plans to use it
A challenging economic environment is constricting biotech deal flow. But for well-capitalized Lantheus, these tough times ...
Benzinga.com2d
Lantheus Holdings Stock Short Interest Report | NASDAQ:LNTH | Benzinga
Short interest in Lantheus Holdings Inc (NASDAQ:LNTH) decreased during the last reporting period, falling from 6.46M to 6.42M. This put 12.34% of the company's publicly available shares short.
Investing14d
Lantheus Holdings Inc (LNTH)
All relevant comments and Lantheus Holdings Inc share chat regarding the LNTH NASDAQ share news are listed here in the LNTH forum. View and contribute to the LNTH share chat. Discuss Lantheus Holdings ...
ETF Daily News16d
Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Position Cut by Schroder Investment Management Group
Lantheus Holdings, Inc. has a 52 week low of $58.46 and a 52 week high of $126.89. The stock has a market cap of $6.23 billion, a P/E ratio of 15.13 and a beta of 0.38. Want More Great Investing ...
Nasdaq16d
LNTH Quantitative Stock Analysis
Below is Validea's guru fundamental report for LANTHEUS HOLDINGS INC (LNTH). Of the 22 guru strategies we follow, LNTH rates highest using our Twin Momentum Investor model based on the published ...
PharmiWeb18d
Contrast Media Market to Expand at 5-6% CAGR by 2029 | Growing Healthcare Investments and Technological Innovations
For instance, In March 2024, Lantheus Holdings, Inc. declared that the U.S. Food and Drug Administration (FDA) had approved the supplemental new drug application (sNDA) for DEFINITY (Perflutren Lipid ...
The Globe and Mail19d
Lantheus Completes Acquisition of Evergreen Theragnostics
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical ...
Taiwan News20d
Lantheus Completes Acquisition of Evergreen Theragnostics
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling ...
The National Law Review20d
Lantheus Completes Acquisition of Evergreen Theragnostics
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to ...
Investing21d
Lantheus bolsters radiopharmaceutical portfolio with acquisition
BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical industry, announced today the completion of its acquisition of Evergreen Theragnostics, Inc., a ...
Seeking Alpha21d
Lantheus Completes Acquisition of Evergreen Theragnostics
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow ...